Internal Medicine, Gastroenterology · Meriden, CT
NPI
1629077714
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
455 Lewis Ave, Suite 105
Meriden, CT, 06451
Phone (203) 237-2477
Groups this clinician bills Medicare through
Medicare paid, 2024
$290K
5,025 services
Medicare patients, 2024
671
Average age 70
Drug cost, 2024
$2.3M
9,164 prescriptions
Company payments, 2025
$21K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Housein M Wazaz was code 99213 (office e&m - established), 1,102 times for 440 patients. In total Housein M Wazaz billed 5,025 services in 57 codes, and Medicare paid $290K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,102 | 440 | $66.82 | $74K |
| 88305 Surgical Pathology Examination | Office | 1,064 | 227 | $29.62 | $32K |
| 88313 Surgical Pathology Examination | Office | 586 | 152 | $59.72 | $35K |
| 88312 Surgical Pathology Examination | Office | 361 | 149 | $72.84 | $26K |
| 43239 Upper GI Endoscopy | Facility | 177 | 161 | $71.31 | $13K |
| 99203 Office E&M - New | Office | 165 | 165 | $71.76 | $12K |
| 45380 Lower GI Endoscopy - Other | Facility | 134 | 132 | $116.07 | $16K |
| 99214 Office E&M - Established | Office | 59 | 50 | $101.92 | $6,013 |
| 99232 Hospital E&M - Subsequent | Facility | 54 | 31 | $62.17 | $3,357 |
| 45385 Colonoscopy - Lesion Removal | Facility | 50 | 49 | $210.14 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 31 | $95.17 | $4,283 |
| 99221 Hospital E&M - Initial | Facility | 39 | 38 | $66.91 | $2,609 |
| 46221 Digestive/Gastrointestinal | Office | 31 | 11 | $226.20 | $7,012 |
| 45378 Lower GI Endoscopy - Other | Facility | 26 | 24 | $104.64 | $2,721 |
| 99223 Hospital E&M - Initial | Facility | 26 | 23 | $132.84 | $3,454 |
By year: 2022 $257K for 3,877 services; 2023 $263K for 3,966 services; 2024 $290K for 5,025 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 1,064 | 227 | $29.62 | $32K |
| 88313 Surgical Pathology Examination | 586 | 152 | $59.72 | $35K |
| 88312 Surgical Pathology Examination | 361 | 149 | $72.84 | $26K |
Medicare prescription drug claims, 2024
In 2024, the drug Housein M Wazaz prescribed most often to Medicare patients was Pantoprazole Sodium, with 2,126 prescriptions and refills. In total Housein M Wazaz wrote 9,164 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 2,126 | 4,977 | 674 | $28K |
| Metoclopramide Hcl Generic | 1,098 | 1,211 | 282 | $5,486 |
| Famotidine Generic | 1,045 | 2,088 | 289 | $14K |
| Linzess Linaclotide | 685 | 1,070 | 197 | $586K |
| Omeprazole Generic | 625 | 1,399 | 180 | $8,012 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 580 | 580 | 537 | $33K |
| Esomeprazole Magnesium Generic | 471 | 1,190 | 173 | $21K |
| Sucralfate Generic | 207 | 225 | 71 | $22K |
| Dicyclomine Hcl Generic | 156 | 226 | 71 | $2,516 |
| Lubiprostone Generic | 119 | 133 | 18 | $13K |
| Dexlansoprazole Dr Dexlansoprazole | 109 | 229 | 27 | $30K |
| Ursodiol Generic | 90 | 126 | Under 11 | $11K |
| Lansoprazole Generic | 79 | 163 | 22 | $1,836 |
| Amitriptyline Hcl Generic | 76 | 154 | 26 | $1,260 |
| Motegrity Prucalopride Succinate | 73 | 93 | 18 | $48K |
Brand drugs: - claims; generic drugs: 7,393 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Housein M Wazaz $21K ($21K in general payments such as food, travel and fees) from 16 companies. The largest payer was Phathom Pharmaceuticals, Inc. with $7,775.
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. PHAT | 32 | $7,775 |
| Lilly USA, LLC LLY | 28 | $6,712 |
| Aimmune Therapeutics, Inc. | 3 | $4,050 |
| Abbvie Inc. ABBV | 38 | $554 |
| Gilead Sciences, Inc. GILD | 23 | $362 |
| Pfizer Inc. PFE | 21 | $273 |
| Madrigal Pharmaceuticals MDGL | 3 | $181 |
| Janssen Biotech, Inc. JNJ | 3 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $139 |
| Ardelyx, Inc. ARDX | 3 | $77.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.